Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 9/20 | 0.32 |
| ▸ | S1PR3 | Q99500 | 8/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | ACP1 | P24666 | 4/20 | 0.32 |
| ▸ | CETP | P11597 | 1/20 | 0.31 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.31 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.31 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29189969 | 0.99 | S1PR1 (0.32) | S1PR1S1PR3CHRNA7KCNH2ACP1 | |
| SCHEMBL29189931 | 0.89 | VSIR (0.36) | S1PR1S1PR3 | |
| SCHEMBL29189950 | 0.89 | CHRNA7 (0.39) | S1PR1S1PR3CHRNA7KCNH2ACP1 | |
| SCHEMBL29189924 | 0.86 | CHRNA7 (0.31) | S1PR1S1PR3CHRNA7KCNH2CETP | |
| SCHEMBL29189986 | 0.86 | S1PR1 (0.36) | S1PR1S1PR3 | |
| SCHEMBL29189949 | 0.85 | S1PR1 (0.36) | S1PR1S1PR3 | |
| SCHEMBL29189982 | 0.84 | S1PR1 (0.35) | S1PR1S1PR3KCNH2 | |
| SCHEMBL24818797 | 0.83 | VSIR (0.34) | S1PR1S1PR3ACP1CETP | |
| SCHEMBL30152636 | 0.83 | VSIR (0.34) | S1PR1S1PR3ACP1CETP | |
| SCHEMBL29190104 | 0.83 | S1PR1 (0.36) | S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117858865-A | CBL-B modulators and uses thereof | 林伯士克莱奥公司 | 2024-04-09 | — | — | CN | disclosed |